Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 6
2021 6
2022 6
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
Nolasco S, Portacci A, Campisi R, Buonamico E, Pelaia C, Benfante A, Triggiani M, Spadaro G, Caiaffa MF, Scioscia G, Detoraki A, Valenti G, Papia F, Tomasello A, Crimi N, Scichilone N, Pelaia G, Carpagnano GE, Crimi C. Nolasco S, et al. Among authors: buonamico e. Front Immunol. 2023 Jun 30;14:1204444. doi: 10.3389/fimmu.2023.1204444. eCollection 2023. Front Immunol. 2023. PMID: 37457743 Free PMC article.
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
Portacci A, Campisi R, Buonamico E, Nolasco S, Pelaia C, Crimi N, Benfante A, Triggiani M, Spadaro G, Caiaffa MF, Scioscia G, Detoraki A, Valenti G, Papia F, Tomasello A, Scichilone N, Pelaia G, Crimi C, Carpagnano GE. Portacci A, et al. Among authors: buonamico e. ERJ Open Res. 2023 Oct 30;9(5):00419-2023. doi: 10.1183/23120541.00419-2023. eCollection 2023 Sep. ERJ Open Res. 2023. PMID: 37908397 Free PMC article.
The Predictors of Long COVID in Southeastern Italy.
Quaranta VN, Portacci A, Dragonieri S, Locorotondo C, Buonamico E, Diaferia F, Iorillo I, Quaranta S, Carpagnano GE. Quaranta VN, et al. Among authors: buonamico e. J Clin Med. 2023 Sep 29;12(19):6303. doi: 10.3390/jcm12196303. J Clin Med. 2023. PMID: 37834947 Free PMC article.
Asthma and Fixed Airways Obstruction: Real Life Aspects.
Buonamico E, Portacci A, Dragonieri S, Quaranta VN, Diaferia F, Capozza E, Macchia L, Carpagnano GE. Buonamico E, et al. Adv Respir Med. 2023 Feb 4;91(1):66-73. doi: 10.3390/arm91010007. Adv Respir Med. 2023. PMID: 36825941 Free PMC article.
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection.
Bavaro DF, Diella L, Solimando AG, Cicco S, Buonamico E, Stasi C, Ciannarella M, Marrone M, Carpagnano F, Resta O, Carpagnano GE, Palmieri VO, Vacca A, Dell'Aera M, Dell'Erba A, Migliore G, Aricò M, Saracino A. Bavaro DF, et al. Among authors: buonamico e. Pathog Glob Health. 2022 Jul;116(5):297-304. doi: 10.1080/20477724.2021.2024030. Epub 2022 Feb 9. Pathog Glob Health. 2022. PMID: 35138229 Free PMC article.
Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development?
Portacci A, Amendolara M, Quaranta VN, Iorillo I, Buonamico E, Diaferia F, Quaranta S, Locorotondo C, Schirinzi A, Boniello E, Dragonieri S, Carpagnano GE. Portacci A, et al. Among authors: buonamico e. Respir Med. 2024 May;226:107628. doi: 10.1016/j.rmed.2024.107628. Epub 2024 Apr 12. Respir Med. 2024. PMID: 38615715
25 results